BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

HighTower Advisors, LLC's Holding History (CIK: 0001462245)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 18,030 Value ($000) $141 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 17,100 Value ($000) $130 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 17,000 Value ($000) $152 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 17,061 Value ($000) $128 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 17,600 Value ($000) $132 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 19,059 Value ($000) $146 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 20,150 Value ($000) $124 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 18,150 Value ($000) $92 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 18,150 Value ($000) $109 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 17,949 Value ($000) $126 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 18,600 Value ($000) $131 Avg Close $8.02 Range $6.87 - $9.07
Q4 2020
Shares 25,726 Value ($000) $191 Avg Close $5.16 Range $3.36 - $8.99
Q3 2014
Shares 13,000 Value ($000) $127 Avg Close $12.26 Range $9.78 - $14.62